Cafamol Extra

Quick links to important sections

Cafamol Extra

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cafamol Extra

What is Cafamol Extra: A Quick Definition

To provide an immediate, structured overview of this common medication, here are its key properties:

Property Description
Active Ingredients Paracetamol (Acetaminophen) and Caffeine
Form Typically an Oral Tablet or Capsule
Pharmacological Class Analgesic and Antipyretic Combination
Common Use Symptomatic relief of mild-to-moderate pain and fever
Origin Synthetic Pharmaceutical

Cafamol Extra is an over-the-counter (OTC) combination medication designed primarily as an analgesic and antipyretic, most commonly presented for oral administration in tablet form. This formulation is widely relied upon for the symptomatic relief of common discomforts, positioning it as a first-line option for general pain and fever management.


What is the Composition of Cafamol Extra?

The core components of Cafamol Extra include the key active pharmaceutical ingredients (APIs) Paracetamol (Acetaminophen) and Caffeine. Paracetamol belongs to the aniline analgesic class, providing the essential pain-relieving and fever-reducing actions. The addition of Caffeine, a central nervous system (CNS) stimulant, is a distinguishing feature of this formulation. Caffeine is included as an analgesic adjuvant. The inclusion of Caffeine is recognized for enhancing the speed and power of the pain relief. Both compounds are synthetically produced.


What is Cafamol Extra Used For?

The primary therapeutic purpose of Cafamol Extra is to achieve rapid and effective symptomatic relief from various mild to moderate painful conditions, such as tension headaches or muscle aches, and to reduce fever. The inclusion of Caffeine, unlike single-ingredient Paracetamol, makes the formulation particularly advantageous when the patient needs swift action and relief from pain that may be accompanied by minor fatigue. The formulation utilizes this dual-ingredient approach for symptom management. This indicates that the drug combination is a strategy for efficient, temporary symptom management.

What side effects are possible with Cafamol Extra?

Possible side effects and safety information

The official safety profile for the Paracetamol and Caffeine combination focuses on adverse reactions grouped by frequency and the organ system affected, as documented by regulatory bodies. The adverse reactions are broadly categorized into those related to hypersensitivity (Paracetamol) and those related to Central Nervous System (CNS) and cardiac stimulation (Caffeine).


Official Adverse Reaction Categories

Side effects are classified in official regulatory texts according to their known or estimated frequency:

Frequency Classification Examples of Documented Reactions
Very Rare Serious skin reactions (e.g., Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis), Agranulocytosis, Anaphylaxis, Hepatic dysfunction or failure.
Not Known Insomnia, Restlessness, Anxiety, Palpitations, Tachycardia, Dizziness, Gastrointestinal disturbances (e.g., nausea, vomiting).

Serious adverse reactions noted in official labeling include Acute Liver Failure and Severe Cutaneous Adverse Reactions (SCARs), which are rare but clinically significant consequences linked to the Paracetamol component.


Safety Constraints and Special Populations

The regulatory safety notes define important usage boundaries. Patients are explicitly advised to avoid the concurrent use of other products containing paracetamol to prevent exceeding the safe daily limit and risking hepatotoxicity. Additionally, excessive intake of dietary caffeine must be avoided to mitigate potential stimulant-related side effects. Official documents also note that the risk of Paracetamol-related harm is increased for individuals with non-cirrhotic alcoholic liver disease.

Regarding specific populations, the combination is not recommended for use during pregnancy (due to the caffeine component) or while breastfeeding, as caffeine passes into breast milk and may cause stimulation in the infant.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Overdose involving Cafamol Extra requires urgent attention due to the delayed, severe risks associated with its components. Initial signs may be limited to non-specific gastrointestinal symptoms such as pallor, nausea, and abdominal pain, which may not reflect the full severity of the ingestion. The primary life-threatening outcome is Acute Liver Failure (Hepatotoxicity) from the Paracetamol component, which typically becomes apparent 12 to 48 hours after ingestion and can progress to encephalopathy, cerebral oedema, and death. The caffeine component may contribute to manifestations of CNS stimulation, including restlessness, agitation, tachycardia, and in severe cases, seizures or cardiac arrhythmia. Severe overdose can also lead to systemic complications, including metabolic acidosis and acute renal failure.

When to Seek Urgent Medical Help

Official regulatory guidance mandates that immediate medical advice must be sought at once following any suspected overdose, even if the patient feels well. This action is critical because immediate treatment is essential to mitigate the risk of delayed organ damage. Patients must be referred to the hospital urgently for immediate medical attention. Management procedures include measuring the plasma paracetamol concentration and administering the specific antidote, N-acetylcysteine (NAC), for which the maximum protective effect is achieved when initiated within the first eight hours. Specific risk factors, such as non-cirrhotic alcoholic liver disease or being glutathione deplete, are noted as increasing the hazard of severe hepatotoxicity.

Therapeutic Uses of Cafamol Extra

What Cafamol Extra Treats: Main Uses and Benefits

The primary intent of Cafamol Extra is to provide supportive symptomatic relief for specific domains of discomfort, focusing on short-term assistance when symptoms become more noticeable. This combination is generally considered relevant for the symptomatic management of mild-to-moderate pain and fever, and is applied across domains where additional symptomatic support is needed. The formulation is commonly applied across conditions characterized by episodic or fluctuating symptom patterns that interfere with daily functioning.

This analgesic action helps manage symptoms related to manifestations like tension headaches, migraine episodes, muscular aches, sprains, toothache, and period pains (dysmenorrhoea). It is specifically used to help with symptoms related to systemic imbalance, such as fever and generalized discomfort often experienced during a cold or influenza.

“The primary intent is symptomatic support, helping to ease symptoms that create noticeable physiological strain.”

The combination is considered relevant for managing symptoms that interfere with daily comfort, and the addition of caffeine is relevant for easing challenging symptoms. It is relevant in contexts where short-term symptomatic assistance is needed and an appropriate symptomatic response is desired.


Quick Fact: Support for Acute Symptoms Cafamol Extra is generally applied during phases of increased distress or discomfort associated with acute pain events, contributing to easing the overall symptom load and supporting patients during episodes of heightened discomfort.

Regulatory References

  1. (HPRA Patient Information)

Eligibility and Restrictions for Use

Who Can and Cannot Use Cafamol Extra: Official Regulatory Information

The eligibility profile for Cafamol Extra (Paracetamol/Caffeine) is strictly defined by regulatory authorities based on known risks associated with its active components.

Classification Eligibility Rule (Strictly Label-Based)
Populations Allowed Adults and Adolescents (minimum age thresholds typically begin at 12 or 16 years, depending on regulatory jurisdiction).
Populations Contraindicated Individuals with known Hypersensitivity to Paracetamol or Caffeine. Patients taking other Paracetamol-containing products. Patients with Severe Active Liver Disease or Severe Hepatic Impairment.
Conditional/Restricted Use Use requires caution and professional advice in patients with Non-Severe Hepatic or Renal Impairment, Chronic Alcoholism, High Blood Pressure, or pre-existing Arrhythmia.
Not Recommended The medicine is Not Recommended for Children under 12 years of age. Use is Not Recommended during Pregnancy and Lactation (Breastfeeding).

Age-Related Eligibility: Use is prohibited for infants and children below the stated minimum age. In older adults, use is generally permitted as for adults, but with necessary caution concerning underlying conditions such as renal or hepatic impairment.

Connection to the Overall Eligibility Profile: Regulatory bodies mandate that restrictions focus on preventing Paracetamol overdose and hepatotoxicity (liver-related conditions) and mitigating risks from Caffeine in vulnerable cardiovascular populations. This ensures that only populations with established safety margins are approved for use under labeled conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory authorities have formally established interaction patterns for Cafamol Extra, focusing on the Paracetamol and Caffeine components.

Prohibited Combinations and Official Restrictions

Co-administration with any other medicinal product containing Paracetamol is strictly contraindicated due to the severe risk of overdose. The regulatory label also recommends avoidance of co-use with agents like Beta-blockers, Theophylline, and Disulfiram. Furthermore, the official profile cites regular, excessive consumption of Ethanol (Alcohol) and the use of certain Hepatic Enzyme Inducers (including the herbal product St John's Wort) as risk factors for Paracetamol-related hepatotoxicity.

Pharmacokinetic and Pharmacodynamic Effects

Pharmacokinetic interactions occur with substances that alter the rate of absorption of the Paracetamol component: Metoclopramide or Domperidone may increase the absorption speed, while Cholestyramine may reduce it. For pharmacodynamic risk, prolonged, regular use of Paracetamol enhances the anticoagulant effect of Coumarins (e.g., Warfarin), officially increasing the risk of bleeding. The Caffeine component's clearance is reduced by potent CYP1A2 inhibitors (e.g., Fluvoxamine), leading to increased plasma concentration.

Timing Rules and Specific Cautions

A formal timing separation rule is mandated: treatment with the Caffeine component must be discontinued for at least five days prior to myocardial imaging requiring injectable Dipyridamole. The profile also includes caution notes regarding increased risk of metabolic acidosis when Paracetamol is used in patients in Glutathione-Depleted States.

Mechanism of Action

The dual action of Cafamol Extra is achieved through the coordinated modulation of distinct signaling pathways within the central nervous system (CNS), resulting in a combined physiological action via distinct mechanistic pathways.

Central Modulation of Pain and Temperature Pathways

The primary component acts as a central inhibitor of Cyclooxygenase (COX) enzymes, which reduces the synthesis of Prostaglandin E₂ (PGE₂) in the hypothalamus, thereby modulating the hypothalamic thermal set-point. For pain, the mechanism also involves the engagement of the endocannabinoid system via activation of TRPV1 and CB₁ receptors, which causes an elevation of the physiological pain threshold and dampens nociceptive signals transmitted through the spinal cord.

Adjuvant Potentiation via Adenosine Receptor Blockade

Caffeine contributes as an analgesic adjuvant by acting as a competitive antagonist at central Adenosine receptors (A₁ and A₂ₐ). This interaction blocks adenosine, a neuromodulator that influences pain sensitization and neuronal activity, leading to increased central nervous system activity. By targeting a separate pathway, this mechanism complements the central actions of the primary ingredient, which contributes to the overall physiological effect profile by modulating the speed and extent of the central action.

Mechanistic Limitation: Constraint in Peripheral Inflammation

The COX inhibition mechanism is physiologically constrained in tissues experiencing high peroxide levels, a characteristic feature of severe peripheral inflammatory states. This constraint means the mechanism cannot effectively limit local PGE₂ production in these environments, resulting in a minimal physiological response to peripheral inflammatory processes.

Dosage and Administration Information

Official Administration Guidelines for Cafamol Extra

The administration of Cafamol Extra, which is often a fixed-dose combination product containing Acetaminophen (Paracetamol) and Caffeine, must strictly follow the instructions outlined in the official product labeling.

Dosing and Route

Administration Scope Official Labeled Instruction
Route of Administration Oral (swallowed) only.
Standard Adult Dose One to two tablets or capsules, depending on the product strength and specific formulation.
Dosing Interval The dose may be taken every 4 to 6 hours as needed.
Maximum Daily Limit The total dosage must not exceed the stated limit for the combined ingredients. The total amount of Acetaminophen from all sources in 24 hours must not exceed 4,000 mg (4 grams).
Age Group Rules Approved for adults and children 12 years of age and older. Dosage for children under 12 must be determined by a healthcare professional.
Administration Conditions No specific mandatory requirement to take with or without food is stated in standard labeling, but the dose must be swallowed orally with liquid.

Procedural and Usage Constraints

The correct use protocol is defined by adherence to time intervals and a critical cap on intake. Patients must wait at least the minimum time (4-6 hours) between doses and strictly monitor the total amount of Acetaminophen consumed, including from other medications. The official instructions for this as-needed (PRN) medication dictate that if a regular dose is missed, it should be skipped, and the patient should resume the regular schedule without taking a double dose to catch up, while still respecting the minimum interval. Special caution is noted for patients with renal or hepatic impairment, requiring professional dosage consideration. The core procedural structure ensures dosage is determined by the unit count and interval, constrained by the maximum 24-hour limit.

Recent Clinical Evidence

Cafamol Extra: Recent Clinical Evidence

This section provides a summary of the types of research that have examined this drug. The drug is a combination product, typically containing active ingredients such as paracetamol (acetaminophen) and caffeine. Research has explored the substance's involvement with specific chemical production in relation to inflammation and pain.


Studies in Pain and Symptom Relief

Research has explored whether this combination product is evaluated for use in common pain conditions. Studies evaluated the drug's influence on pain relief in adults with headaches, including migraine, and musculoskeletal discomfort.

  • Combination Efficacy: Studies have focused on the benefits of combining active ingredients, such as paracetamol and caffeine, noting that the addition of caffeine may enhance the action of the analgesic component. Research explored the parameters of acute pain within clinical models.
  • Comparative Research: Research compared the drug's properties against other single-ingredient agents in studies evaluating pain. Findings from some clinical trials have suggested comparable outcomes when evaluated against standard single-agent treatments for specific pain types.

Focus on Safety and Side Effects

Safety profiles are a major focus of research. Studies have reported findings related to potential gastrointestinal and cardiovascular considerations, particularly in the context of the product's components.

  • Co-administration: Research has investigated the co-administration of the substance with other drugs. Studies have highlighted that one component, paracetamol, is present in many other products, and researchers have assessed the importance of total daily intake across all sources to avoid exceeding established limits.
  • Drug-Disease Interactions: Studies have explored the effects on individuals with pre-existing conditions, such as liver or kidney impairment, noting that these conditions may influence how the body processes the medication's components. Research findings were mixed when evaluating the use of analgesic combinations in people with certain chronic conditions.

Key Studies & References

  1. National Institute for Health and Care Excellence (NICE) Clinical Guideline: Headaches in over 12s (Guidance on Combination Analgesics)

Frequently Asked Questions (FAQ)

Common questions about Cafamol Extra (FAQ)


Q: How long does it usually take to feel the effect of Cafamol Extra?

A: The formulation of Cafamol Extra, which includes caffeine, is described in official documents as accelerating the absorption of the primary pain-relieving ingredient. This action is officially described as potentially contributing to a faster onset of action compared to the primary ingredient when used alone.


Q: Does Cafamol Extra stay in the body for a long time?

A: The time it takes for the components to be eliminated from the body generally correlates with the recommended dosing interval, which is typically every four to six hours. For the primary component, regulatory pharmacokinetic data notes an elimination half-life of roughly two to two-and-a-half hours in healthy adults.


Q: Does taking Cafamol Extra make it hard to sleep?

A: Official safety information lists insomnia (difficulty sleeping) as a reported adverse reaction. This effect is generally related to the stimulating properties of the caffeine component in the medicine. The official product label notes the importance of limiting excessive intake of caffeine from all sources to potentially mitigate stimulant-related side effects.


Q: Is Cafamol Extra suitable for use by people with high blood pressure?

A: Regulatory guidance advises that the product should be used with caution and under professional supervision in patients with pre-existing high blood pressure (hypertension). This precaution is related to the stimulating effects of the caffeine component, which may impact cardiovascular status.


Q: Can people with liver conditions use Cafamol Extra?

A: Use is strictly prohibited for individuals with severe active liver disease or severe hepatic impairment. For people with non-severe liver impairment, official documents mandate that use requires caution and professional medical advice. These restrictions reflect the risk associated with the Paracetamol component, which is related to liver damage (hepatotoxicity).


Q: Does Cafamol Extra interact with alcohol?

A: Official product information cites regular, excessive consumption of alcohol (Ethanol) as a risk factor that may increase the potential for Paracetamol-related hepatotoxicity (liver damage). Co-use with alcohol is noted for increasing the risk of serious adverse reactions associated with the medicine's primary ingredient.


Q: Is it true that Cafamol Extra is not suitable for people with anxiety?

A: Official safety documentation lists anxiety, restlessness, excitement, and agitation as possible adverse reactions. These effects are associated with the stimulant effects of the caffeine component. Patients with pre-existing anxiety are noted in regulatory information as a group where use may require caution.


Q: Can Cafamol Extra be crushed or divided, or must it be swallowed whole?

A: The official administration instruction is to swallow the dose orally with liquid. Unless the specific product packaging or labeling explicitly states that the tablet or capsule is scored or designed to be divided, regulatory guidance generally indicates that these forms are intended to be swallowed whole.


Q: Why is monitoring liver function sometimes mentioned in relation to one of Cafamol Extra's ingredients?

A: The primary ingredient, Paracetamol, is associated with a risk of severe liver damage, including acute liver failure, if the maximum daily dose is exceeded. This risk is why official warnings and contraindications regarding liver conditions are included in the product information. These warnings highlight the importance of careful consideration for vulnerable patients.


Q: Is Cafamol Extra available without a prescription?

A: Cafamol Extra is typically classified and marketed in many regulatory jurisdictions as an over-the-counter (OTC) combination medication. This classification generally means it can be purchased without the need for a prescription.


Q: What kind of headaches is Cafamol Extra approved to treat?

A: Official product information states that the medicine is approved for the symptomatic relief of various mild to moderate painful conditions. These indications specifically include tension headaches and, depending on the regulatory jurisdiction, may also include migraine headaches.


Q: Are there any major interactions with common over-the-counter cold medicines?

A: Regulatory documents strictly prohibit co-administration with any other medicinal product containing Paracetamol. Furthermore, caution is advised when taking other over-the-counter cold and flu remedies that contain stimulants (such as pseudoephedrine), as this combination could heighten stimulant-related side effects from the caffeine component.


Q: Does Cafamol Extra help with muscle pain or just headaches?

A: Official regulatory product information states that the medicine is indicated for the symptomatic relief of mild to moderate pain. This approved use includes both muscle aches and musculoskeletal discomfort, in addition to headaches.


Q: What official warnings are associated with Cafamol Extra?

A: The major official warnings defined in regulatory documents focus on the critical risk of severe liver damage from Paracetamol overdose and the potential for rare, but serious, Severe Cutaneous Adverse Reactions (SCARs). The label also includes general warnings related to avoiding excessive caffeine intake.


Q: Is it okay to drive after taking Cafamol Extra?

A: Official safety documents advise that patients should not drive or operate heavy machinery if they experience side effects such as dizziness, lightheadedness, or drowsiness after taking the medicine. The effect of the product on the individual should be assessed before operating a vehicle.


Q: What is the risk of an allergic reaction to Cafamol Extra?

A: Official safety documentation notes that hypersensitivity reactions, including severe forms like anaphylaxis and serious skin reactions, are possible. However, these are typically classified as Very Rare. Official documentation states that if signs of an allergic reaction occur, immediate professional medical attention is recommended.


Q: Does Cafamol Extra interact with prescription medicines for depression?

A: The caffeine component may interact with certain medications that are strong inhibitors of the CYP1A2 liver enzyme, which includes some prescription medicines used to treat depression. This interaction can potentially slow the breakdown of caffeine, leading to increased concentration in the body.


Q: Is there a generic version of Cafamol Extra available?

A: As a combination of two common and established active ingredients (Paracetamol and Caffeine), numerous generic formulations containing these components are typically available. These generic products are marketed under different brand names.


Q: Can Cafamol Extra be used for period pain?

A: Official regulatory documents in many jurisdictions include the relief of menstrual pain (period pains or dysmenorrhea) as an approved indication for the Paracetamol/Caffeine combination product.


Q: What is the difference between an adverse reaction and a side effect mentioned in the documentation?

A: In the context of regulatory drug documentation, the terms 'adverse reaction' and 'side effect' are often used broadly and interchangeably to refer to any unintended and potentially harmful effect of the medication. Official texts categorize these effects primarily based on their known frequency and severity.


Q: Are there any known interactions between Cafamol Extra and herbal supplements?

A: The regulatory profile explicitly mentions that certain herbal products, such as St John's Wort, may increase the risk of Paracetamol-related liver damage because they can act as hepatic enzyme inducers. Due to the potential for other supplements to affect liver enzymes or caffeine breakdown, general caution is noted.


Q: What evidence exists about the combination of ingredients in Cafamol Extra working better together?

A: Clinical research and regulatory assessments support that the caffeine component acts as an analgesic adjuvant. Studies suggest that the caffeine component may potentiate the pain-relieving action of the primary ingredient compared to the primary ingredient when used alone in acute pain models.


Q: Are there any restrictions on when Cafamol Extra should be taken during the day?

A: Official administration instructions define a minimum time interval between doses, typically four to six hours, but do not mandate a specific time of day for administration. Due to the potential for the caffeine component to cause insomnia, consideration is often given to avoiding doses taken close to bedtime.


Q: What happens if I forget to take Cafamol Extra as scheduled?

A: The official protocol for this as-needed (PRN) medicine dictates that a missed dose should be skipped. The patient should then resume the regular schedule without taking a double dose to compensate, while always respecting the minimum time interval between doses.

How should Cafamol Extra be stored and disposed of?

How to Store and Dispose of Cafamol Extra?

The storage and disposal of Cafamol Extra must strictly adhere to the requirements documented in official regulatory labeling to ensure product stability and safety.


Storage Requirements

The medicine must be stored at controlled room temperature, typically defined as below 25 C or 30 C. It is mandatory to keep the product in its original container and protect it from light and moisture.

  • Do not freeze the medicine.
  • Store the product out of the reach and sight of children.
  • Do not use the medicine after the expiry date printed on the packaging.

Disposal Instructions

Unused or expired Cafamol Extra must not be thrown into household trash or disposed of via wastewater (sink or toilet). Disposal must follow local pharmaceutical waste regulations.

  • Utilize a designated drug take-back program or a local collection point for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cafamol Extra found in:

A-Z Index: